DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Levocetirizine Dihydrochloride is a drug marketed by Apotex, L Perrigo Co, Lannett Co Inc, Taro Pharm Inds Ltd, Dr Reddys Labs Ltd, Fosun Pharma, Glenmark Generics, Hetero Labs Ltd Iii, Macleods Pharms Ltd, Micro Labs, Micro Labs Ltd India, Neopharma, Perrigo R And D, Sciegen Pharms Inc, Sun Pharm, Sun Pharm Inds Ltd, Synthon Pharms, and Teva Pharms. and is included in twenty-one NDAs.
The generic ingredient in LEVOCETIRIZINE DIHYDROCHLORIDE is levocetirizine dihydrochloride. There are thirteen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the levocetirizine dihydrochloride profile page.
A generic version of LEVOCETIRIZINE DIHYDROCHLORIDE was approved as levocetirizine dihydrochloride by SYNTHON PHARMS on November 26th, 2010.
Summary for LEVOCETIRIZINE DIHYDROCHLORIDE
Recent Clinical Trials for LEVOCETIRIZINE DIHYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Postgraduate Institute of Medical Education and Research||Phase 4|
|University Hospital, Grenoble||Phase 4|
|Zensei Pharmaceutical Co., Ltd.||Phase 1|